NET PROFIT (x1000 DKK)
Centrum för Andrologi och Urologi i Sverige AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
0
|
1
|
0 |
Earnings before taxes |
1,044
|
1,506
|
592 |
EBITDA |
-14
|
-16
|
-14 |
Total assets |
5,946
|
5,943
|
6,513 |
Current assets |
627
|
601
|
554 |
Current liabilities |
887
|
1,411
|
2,672 |
Equity capital |
4,783
|
4,267
|
3,562 |
- share capital |
34
|
33
|
36 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
80.4%
|
71.8%
|
54.7% |
Turnover per employee | |||
Profit as a percentage of turnover | |||
Return on assets (ROA) |
17.6%
|
25.4%
|
9.1% |
Current ratio |
70.7%
|
42.6%
|
20.7% |
Return on equity (ROE) |
21.8%
|
35.3%
|
16.6% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.